{"id":"https://openalex.org/W4399519802","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6530","title":"Achievement of therapeutic levels using dose-reduced peg-asparaginase in adult patients with acute lymphoblastic leukemia.","display_name":"Achievement of therapeutic levels using dose-reduced peg-asparaginase in adult patients with acute lymphoblastic leukemia.","publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399519802","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6530"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.6530","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6530","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081078616","display_name":"Leah Ann Goldberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leah Ann Goldberg","raw_affiliation_strings":["Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022354133","display_name":"Anjani D. Kapadia","orcid":"https://orcid.org/0000-0003-4072-2019","observed_orcids":["https://orcid.org/0000-0003-4072-2019"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjani Kapadia","raw_affiliation_strings":["Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016312496","display_name":"Andrew John Palmer","orcid":"https://orcid.org/0000-0002-9703-7891","observed_orcids":["https://orcid.org/0000-0002-9703-7891"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Palmer","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114175416","display_name":"Syed Abdul Mannan Shah","orcid":"https://orcid.org/0009-0006-8965-233X","observed_orcids":["https://orcid.org/0009-0006-8965-233X"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syed Abdul Mannan Shah","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025319514","display_name":"Hamed Rahmani Youshanlouei","orcid":"https://orcid.org/0000-0003-0263-8895","observed_orcids":["https://orcid.org/0000-0003-0263-8895"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamed Rahmani Youshanlouei","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058055734","display_name":"Adam S. DuVall","orcid":"https://orcid.org/0000-0002-9163-8792","observed_orcids":["https://orcid.org/0000-0002-9163-8792"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam DuVall","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013847725","display_name":"Emily Dworkin","orcid":"https://orcid.org/0009-0003-8459-7456","observed_orcids":["https://orcid.org/0009-0003-8459-7456"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Dworkin","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038290613","display_name":"Anand Ashwin Patel","orcid":"https://orcid.org/0000-0002-0296-8686","observed_orcids":["https://orcid.org/0000-0002-0296-8686"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anand Ashwin Patel","raw_affiliation_strings":["Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"6530","last_page":"6530"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peg-asparaginase","display_name":"PEG-asparaginase","score":0.9890000224113464},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.8379999995231628},{"id":"https://openalex.org/keywords/asparagine-depletion","display_name":"asparagine depletion","score":0.781000018119812},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.8130000233650208},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9150000214576721},{"id":"https://openalex.org/keywords/lymphoblastic-lymphoma","display_name":"lymphoblastic lymphoma","score":0.7910000085830688},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/erwinia-asparaginase","display_name":"Erwinia asparaginase","score":0.8389999866485596},{"id":"https://openalex.org/keywords/adolescents-and-young-adults","display_name":"adolescents and young adults","score":0.6269999742507935},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8994190692901611},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.7667529582977295},{"id":"https://openalex.org/C2778904437","wikidata":"https://www.wikidata.org/wiki/Q105296036","display_name":"Asparaginase","level":4,"score":0.6781585812568665},{"id":"https://openalex.org/C54400483","wikidata":"https://www.wikidata.org/wiki/Q1793202","display_name":"PEG ratio","level":2,"score":0.5919398069381714},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.4631267189979553},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40034109354019165},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3854180574417114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32126036286354065},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.6530","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.6530","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.6530","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2983476584","https://openalex.org/W2890594313","https://openalex.org/W7108482784","https://openalex.org/W2346765674","https://openalex.org/W2809530815","https://openalex.org/W2131521161","https://openalex.org/W2589503004","https://openalex.org/W2981052366","https://openalex.org/W4405044952","https://openalex.org/W4379984950"],"abstract_inverted_index":{"6530":[0],"Background:":[1],"Peg-asparaginase":[2],"(PEG)":[3],"doses":[4],"range":[5],"from":[6,125,247],"2000-2500":[7],"IU/m2":[8,217],"in":[9,20,28,77,108,329,379],"pediatric-inspired":[10],"regimens":[11],"for":[12,50,131],"acute":[13],"lymphoblastic":[14,119],"leukemia":[15],"(ALL).":[16],"Pediatric":[17],"PEG":[18,71,86,107,124,138,154,185,233,248,359],"dosing":[19,43],"adolescents":[21],"and":[22,37,101,160,197,218,274,289,301,317,322],"young":[23],"adults":[24,109],"(AYAs)":[25],"has":[26],"resulted":[27],"improved":[29],"outcomes,":[30],"but":[31],"PEG-associated":[32],"toxicities":[33,103,172,290],"increase":[34],"with":[35,110,116,136,165,232,268,272,277,368,381],"age":[36,189,348],"often":[38],"limit":[39],"its":[40],"use.":[41],"Therapeutic":[42],"is":[44],"determined":[45],"by":[46],"asparagine":[47],"(ASP)":[48],"depletion":[49,100,303,367],"14":[51,161,306],"days":[52,84,144,162,307],"after":[53,104,145,239],"dose;":[54],"L-asparaginase":[55,82,299],"levels":[56,155,300],"can":[57],"act":[58],"as":[59,73,142],"a":[60,278],"surrogate":[61],"marker":[62],"of":[63,80,98,181,241,297,315,320],"ASP":[64,99,302,366],"depletion.":[65],"We":[66],"previously":[67],"showed":[68],"dose":[69,105,207,226,287,309,360],"reduced":[70,106,371],"(defined":[72,141],"<2000":[74],"IU/m2)":[75],"results":[76],"high":[78],"rates":[79,314,319,327],"therapeutic":[81,153,238,298,365],"7":[83,159],"post":[85,163],"(Derman":[87],"et":[88,334],"al,":[89,335],"Leuk":[90],"Lymphoma":[91],"2020).":[92],"Here":[93],"we":[94],"describe":[95],"prolonged":[96],"duration":[97],"comparable":[102,318,369],"ALL.":[111,201,382],"Methods:":[112],"Patients":[113],"\u226518":[114],"years":[115],"ALL":[117],"or":[118,370],"lymphoma":[120],"(LBL)":[121],"who":[122],"received":[123,184,204,213,221],"1/1/2008":[126],"to":[127,215,249,253,326],"9/28/2023":[128],"were":[129,147,195,237,245,312],"identified":[130],"retrospective":[132],"chart":[133],"review.":[134],"Those":[135],"\u22651":[137,262],"trough":[139,234],"level":[140,288],"10-20":[143],"dose)":[146],"included.":[148],"The":[149],"primary":[150],"endpoint":[151,167],"was":[152,190,227,282,349],"(\u22650.1IU/mL":[156],"L-asparaginase)":[157],"at":[158],"administration,":[164],"secondary":[166],"being":[168],"induction":[169,206],"grade":[170,263],"3+":[171],"(CTCAE":[173],"v.5.0).":[174],"Results:":[175],"49":[176],"patients":[177,244,260],"met":[178],"inclusion":[179],"criteria,":[180],"which":[182,338],"48":[183],"during":[186],"induction.":[187],"Median":[188],"34.7":[191],"(range":[192],"18-66),":[193],"67%":[194],"male":[196],"53%":[198],"had":[199,261],"B-cell":[200],"17":[202],"(35%)":[203],"an":[205],"\u2264":[208],"500":[209],"IU/m2,":[210],"22":[211],"(46%)":[212],"501":[214],"\u22641000":[216],"9":[219],"(19%)":[220],">1000":[222],"IU/m2.":[223,229],"Induction":[224],"median":[225,347],"1000":[228],"Among":[230],"those":[231,353],"levels,":[235],"79%":[236],"induction;":[240],"note,":[242],"4":[243],"transitioned":[246],"Erwinia":[250],"asparaginase":[251],"due":[252],"silent":[254],"inactivation.":[255],"During":[256],"induction,":[257],"23":[258],"(48%)":[259],"3+toxicity,":[264],"including":[265],"5":[266],"(10%)":[267],"hepatotoxicity,":[269],"1":[270],"(2%)":[271],"pancreatitis,":[273],"2":[275],"(4%)":[276],"thrombotic":[279,323],"event.":[280],"There":[281,311],"no":[283],"statistical":[284],"relationship":[285],"between":[286],"(p=.8).":[291],"Conclusions:":[292],"This":[293,357],"study":[294],"demonstrates":[295],"durability":[296],"that":[304],"persists":[305],"despite":[308],"reduction.":[310],"decreased":[313],"hepatotoxicity":[316],"pancreatitis":[321],"events":[324],"compared":[325],"reported":[328],"CALBG":[330],"10403":[331],"(C10403)":[332],"(Stock":[333],"Blood":[336],"2019),":[337],"utilized":[339],"standard":[340],"pediatric":[341],"dosing.":[342],"In":[343],"addition,":[344],"our":[345],"cohort\u2019s":[346],"significantly":[350],"older":[351],"than":[352],"treated":[354],"on":[355],"C10403.":[356],"suggests":[358],"reduction":[361,374],"may":[362],"offer":[363],"similar":[364],"toxicities.":[372],"Dose":[373],"should":[375],"be":[376],"studied":[377],"prospectively":[378],"AYAs":[380],"[Table:":[383],"see":[384],"text]":[385]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-12T00:00:00"}